Article Versions Notes

Gravina GL, Mancini A, Colapietro A, Monache SD, Sferra R, Vitale F, Cristiano L, Martellucci S, Marampon F, Mattei V, et al. RETRACTED: Gravina et al. The Small Molecule Ephrin Receptor Inhibitor, GLPG1790, Reduces Renewal Capabilities of Cancer Stem Cells, Showing Anti-Tumour Efficacy on Preclinical Glioblastoma Models. Cancers 2019, 11, 359. Cancers. 2026; 18(1):135. https://doi.org/10.3390/cancers18010135

Gravina, Giovanni Luca, Andrea Mancini, Alessandro Colapietro, Simona Delle Monache, Roberta Sferra, Flora Vitale, Loredana Cristiano, Stefano Martellucci, Francesco Marampon, Vincenzo Mattei, and et al. 2026. "RETRACTED: Gravina et al. The Small Molecule Ephrin Receptor Inhibitor, GLPG1790, Reduces Renewal Capabilities of Cancer Stem Cells, Showing Anti-Tumour Efficacy on Preclinical Glioblastoma Models. Cancers 2019, 11, 359" Cancers 18, no. 1: 135. https://doi.org/10.3390/cancers18010135

Gravina, G. L., Mancini, A., Colapietro, A., Monache, S. D., Sferra, R., Vitale, F., Cristiano, L., Martellucci, S., Marampon, F., Mattei, V., Beirinckx, F., Pujuguet, P., Saniere, L., Lorenzon, G., Aar, E. v. d., & Festuccia, C. (2026). RETRACTED: Gravina et al. The Small Molecule Ephrin Receptor Inhibitor, GLPG1790, Reduces Renewal Capabilities of Cancer Stem Cells, Showing Anti-Tumour Efficacy on Preclinical Glioblastoma Models. Cancers 2019, 11, 359. Cancers, 18(1), 135. https://doi.org/10.3390/cancers18010135